| Literature DB >> 27708230 |
Yoon Yang Jung1, Ji Hae Nahm2, Hyun-Soo Kim3.
Abstract
A retrospective analysis was performed to describe the cytomorphological and histopathological findings and human papillomavirus (HPV) genotypes for glassy cell carcinoma (GCC) of the uterine cervix. Five cases of cervical GCC, in which the glassy cell features constituted at least 95% of the specimen, were included. Four patients had stage IIB GCCs and one had stage IIIB GCC. All patients underwent concurrent chemoradiation therapy. Based on pretreatment cytology, only 1 of the 5 cases was correctly diagnosed as GCC. The remaining cases were diagnosed as carcinoma of undetermined type, adenocarcinoma, poorly differentiated carcinoma, or unsatisfactory for evaluation. Cytological specimens had moderate cellularity and contained small clusters of tumor cells admixed with amphophilic, granular tumor diathesis. The tumor cells possessed large, round to oval nuclei and abundant, granular, ground-glass cytoplasm. The nuclei exhibited prominent eosinophilic nucleoli. The cytoplasm displayed sharp margins and molding, resulting in "intercellular windows" between neighboring attached cells. HPV genotyping revealed that high-risk HPV types 18, 16, and 31 were detected in 3, 1, and 1 cases, respectively. Consistent with this finding, all cases exhibited block p16 positivity, confirming the association of HPV infection with GCC. In conclusion, a distinct cytoplasmic margin, the characteristic histopathological feature of GCC, was observed in liquid-based cytological preparations. We suggest that sharp cytoplasmic outlines with molding and intercellular windows are characteristic cytomorphological features of GCC. Detection of high-risk HPV in all cases strongly supported the notion that high-risk HPV is involved in the pathogenesis of GCC.Entities:
Keywords: cervix; cytology; glassy cell carcinoma; human papillomavirus
Mesh:
Year: 2016 PMID: 27708230 PMCID: PMC5342042 DOI: 10.18632/oncotarget.12361
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
Results of cytology, biopsy, immunostaining, and HPV genotyping and treatment of cervical GCC
| Case | Age | FIGO stage | Cytology result | Biopsy result | Immunostaining result | HPV genotype | Treatment | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| p40 | CEA | ER | PgR | p16 | |||||||
| 1 | 38 | IIB | Carcinoma, type undetermined | GCC | Negative | Negative | Negative | Negative | Block positive | HR HPV (type 18) detected | CCRT |
| 2 | 63 | IIB | Adenocarcinoma | GCC | Negative | Negative | Negative | Negative | Block positive | HR HPV (type 16) detected | CCRT |
| 3 | 36 | IIB | Unsatisfactory/GCC | GCC | Negative | Negative | Negative | Negative | Block positive | HR HPV (type 31) detected | CCRT |
| 4 | 67 | IIIB | GCC | GCC | Negative | Negative | Negative | Negative | Block positive | HR HPV (type 18) detected | CCRT |
| 5 | 37 | IIB | Poorly differentiated carcinoma | GCC | Negative | Negative | Focal positive | Focal positive | Block positive | HR HPV (type 18) detected | CCRT |
Abbreviations: CCRT: concurrent chemoradiation therapy, CEA: carcinoembryonic antigen, ER: estrogen receptor; FIGO: International Federation of Gynecology and Obstetrics, GCC: glassy cell carcinoma, HPV: human papillomavirus, HR: high-risk, PgR: progesterone receptor;
At the time of recurrence
Figure 1Liquid-based cytological findings of cervical glassy cell carcinoma
A. Thinprep preparation of the cervical sample shows amphophilic, granular necrotic debris (tumor diathesis) and a few small clusters of polygonal tumor cells. B. The tumor cell clusters or individually scattered tumor cells are unevenly distributed. Tumor diathesis is apparent. C. Although some tumor cells display endocervical-like pseudocolumnar arrangements (black arrowheads), there is no definite evidence of glandular differentiation. A white arrow indicates the intercellular window. D. The tumor cells have relatively fine chromatin and prominent, solitary nucleoli. Abundant, cyanophilic cytoplasm and discrete cell borders (white arrows) are evident. E. Under high-power magnification (×400), the tumor cells show large, oval to round, pleomorphic nuclei and “intercellular windows” produced by discrete cytoplasmic outlines and cytoplasmic molding (white arrow). There are no intercellular bridges. F. Tumor cells are 3–7 fold larger than lymphocytes or neutrophils. Chromatin distribution irregularities, hyperchromasia, and significant anisonucleosis are apparent. G-I. In several areas, an intimate admixture of neutrophils (red circles) and tumor cells, so-called granuloepithelial complexes, is seen. Cytoplasmic molding and intercellular windows (white arrows) are observed. J-K. Mitotic figures (blue arrows) are present. L. Atypical mitotic figures (red arrow) are also detected (A-L, Papanicolaou stain).
Figure 2Histopathological and immunohistochemical findings of cervical glassy cell carcinoma
A. Glassy cell carcinoma consists of tumor cell nests with pale to eosinophilic, abundant cytoplasm. Mitotic figures are frequently observed (blue arrow). B. The tumor cell nests are surrounded by thin fibrovascular connective tissue septa with lymphoplasmacytic infiltrate. A blue arrow indicates a mitotic figure within the tumor cell. C. The individual tumor cells display large nuclei with single, prominent nucleoli. D. Tumor cell cytoplasm possesses eosinophilic, granular cytoplasm, and some exhibit variable-sized microvacuoles. In several areas, mitotic figures are frequent (blue arrow), including abnormal forms (red arrows). E. The tumor cells show distinct cytoplasmic margins and “intercellular windows” (white arrows), which are also apparent in cytological specimens. F. Under high-power magnification (×400), cytoplasmic molding and clear, slit-like intercellular spaces (white arrows) are obviously observed, but intercellular bridging is absent. G. Some bizarre multinucleated giant cells are noted. H. Although cells with a pseudocolumnar arrangement can be seen (black arrowheads), there is no definite evidence of gland formation. I-M. Immunohistochemically, some tumor cells are positive for (I) estrogen receptor and (J) progesterone receptor in a single case. None of the cases examined shows immunoreactivity for (K) p40 or (L) carcinoembryonic antigen. In contrast, all cases exhibited block positivity for (M) p16 (A-H, hematoxylin and eosin stain; I-M, polymer method).
Previously reported HPV prevalence rate and genotypes in cervical GCC
| Year published | Author | HPV prevalence rate | HPV genotype | ||
|---|---|---|---|---|---|
| Category | Type (number of case) | Detection method | |||
| 1998 | Kenny et al. [ | 27.8% (5/18) | HR | 18 (4), 16 (1) | ISH |
| 2002 | Kato et al. [ | 66.7% (2/3) | HR | 18 (2) | PCR |
| 2004 | Hirai et al. [ | 100.0% (2/2) | HR | 18 (2) | PCR |
| 2004 | Ng et al. [ | 0.0% (0/1) | Not detected | PCR-RFLP | |
| 2004 | Matthews-Greer et al. [ | 100.0% (1/1) | HR | 16 (1) | PCR |
| 2009 | Kim et al. [ | 55.6% (5/9) | HR and LR | 18 (2), 31+32 (1),35+68+32 (1), 39+6 (1) | DNA chip |
| 2016 | Jung et al. | 100.0% (5/5) | HR | 18 (3), 16 (1), 31 (1) | DNA chip |
| 1998-2016 | Total | 51.3% (20/39) | HR | 18 (65.0%; 13/20), | |
| LR | 32 (10.0%; 2/20), | ||||
Abbreviations: HPV: human papillomavirus, HR: high-risk, ISH: in situ hybridization, LR: low-risk, PCR: polymerase chain reaction, PCR-RFLP: polymerase chain reaction-restriction fragment length pleomorphism assay;
The present study
Antibodies used for immunohistochemical staining
| Antibody | Source | Clone | Dilution |
|---|---|---|---|
| Carcinoembryonic antigen | Dako, Agilent Technologies Inc., Carpinteria, CA, USA | II-7 | 1:400 |
| Estrogen receptor | Thermo Fisher Scientific Inc., Fremont, CA, USA | SP1 | 1:100 |
| Progesterone receptor | Dako, Agilent Technologies Inc., Carpinteria, CA, USA | PgR 636 | 1:50 |
| p16 | Ventana Medical Systems, Tucson, AZ, USA | E6H4 | Prediluted |
| p40 | Biocare Medical, Concord, CA, USA | Polyclonal | 1:200 |